Global Active Wound Care Market Segmentation, By Product Type (Allograft, Synthetic Skin Grafts, Xenografts, Collagen Dressings, Amniotic Tissue Grafts, Growth Factors), Indication (Burns, Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers), Wound Type (Chronic Wounds, Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings, Others) - Industry Trends and Forecast to 2031.
Active Wound Care Market Analysis
Advanced wound dressing is largely used for the treatment of chronic and non-healing wounds. Therefore, the rising in number of chronic wounds such as diabetic foot ulcers is estimated to help the wound care market to grow. The diabetic foot ulcer is expected to acquire traction as a growing number of people get the condition as a result of the rising prevalence of diabetes. Foot ulcers are one of the most common and feared consequences of diabetes in impoverished countries. According to the International Diabetes Federation (IDF), there are currently over 460 million persons aged 20 to 79 living with diabetes globally, with this number anticipated to climb to 700 million by 2045.
Active Wound Care Market Size
Global active wound care market size was valued at USD 1.83 billion in 2023 and is projected to reach USD 2.74 billion by 2031, with a CAGR of 5.15% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Active Wound Care Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Mölnlycke Health Care AB. (Sweden), Smith & Nephew plc (UK), Medline Industries, Inc. (US), AVITA Medical, (UK) ConvaTec Inc. (UK), Cytori Therapeutics Inc. (US), Human BioSciences (US), Stryker Corporation (US), Organogenesis Inc. (US), and Wright Medical Group N.V. (US)
|
|
Market Opportunities
|
|
Active Wound Care Market Definition
Advanced wound care includes products for treating acute and chronic wounds such ulcers, burns, and post-operative wounds. Advanced wound care treatments including film and foam dressings, hydrogels, alginates, and hydrocolloids keep the wound wet and promote healing without occluding it.
Active Wound Care Market Dynamics
Drivers
- Rise in the diseases and conditions affecting wound healing capabilities
Acute wounds, chronic wounds, and surgical wounds all have a deleterious impact on the wound healing process. Over the last decade, the occurrence of acute, chronic, and surgical wounds has increased dramatically which is further anticipated to propel the growth of the market.
- Increase in the geriatric population
The ageing population is more prone to the development of conditions such as acute wounds, chronic wounds, and surgical wounds. Wounds are more common in the elderly population which is a contributing to the market growth.
- Increasing incidence of various lifestyle disorders
Diabetic foot ulcers, venous leg ulcers, and pressure ulcers are just a few of the lifestyle diseases that can contribute to chronic wounds will further accelerate the market growth.
Opportunities
In addition, the growing awareness of proper wound care management and rising potential in the advancing economies will further provide potential opportunities for the growth of the active wound care market in the coming years.
Restraints/Challenges
On the other hand, the increased cost of advanced wound care products is further projected to impede the growth of the active wound care market in the timeline period. However, the dangers regarding with the usage of advanced wound care products which might further challenge the growth of the active wound care market in the near future.
This active wound care market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the active wound care market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Active Wound Care Market
The COVID-19 had a negative impact on the active wound care market. During the first half of the projection period, the COVID-19 epidemic will have an influence on the wound care market. Because of the lockdowns, the elective surgeries were cancelled or postponed, and rising skin injuries among COVID-19 medical care workers, the wound care industry was negatively impacted. However, with the rapid development of vaccine, countries have opened their international borders, as a result, the active wound care market is expected to impel post COVID-19 period.
Active Wound Care Market Scope
The active wound care market is segmented on the basis of product type, indication, wound type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Allograft
- Synthetic Skin Grafts
- Xenografts
- Collagen Dressings
- Amniotic Tissue Grafts
- Growth Factors
- Platelet Derived Growth Factor (PDGF)
- Platelet Rich Plasma (PRP)
- Epidermal Growth Factors (EGF)
- Basic Fibroblast Growth Factors (BFGF)
- Granulocyte Colony Stimulating Factor (G-CSF)
- Talactoferrin ALFA
- Thrombin Peptide and Keratinocyte Growth Factor (KGF).
Indication
- Burns
- Diabetic Foot Ulcers
- Pressure Ulcers
- Lower Limb Ulcers
Wound Type
- Chronic Wounds
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Ulcers
- Other Chronic Wounds
- Acute Wound
- Surgical and Traumatic Wounds
- Burns
End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- Home Care Settings
- Others
Active Wound Care Market Regional Analysis
The active wound care market is analyzed and market size insights and trends are provided by country, product type, indication, wound type and end user as referenced above.
The countries covered in the active wound care market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the active wound care market due to the occurrence of a large population base. Furthermore, the rise in the patient pool in several countries and growing aging population will further boost the growth of the active wound care market in the region during the forecast period.
Asia-Pacific is projected to observe significant amount of growth of the active wound care market due to the shift in the lifestyles leading and rise in the prevalence of chronic diseases. Moreover, the rising number of surgeries performed is further anticipated to propel the growth of the active wound care market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Active Wound Care Market Share
The active wound care market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to active wound care market.
Active Wound Care Market Leaders Operating in the Market Are:
- Mölnlycke Health Care AB. (Sweden)
- Smith & Nephew plc (UK)
- Medline Industries, Inc. (US)
- AVITA Medical (UK)
- ConvaTec Inc. (UK)
- Cytori Therapeutics Inc. (US)
- Human BioSciences (US)
- Stryker Corporation (US)
- Organogenesis Inc. (US)
- Wright Medical Group N.V. (US)
Latest Development in Active Wound Care Market
- Integra LifeSciences finalised the acquisition of Acell Inc. in January 2021. Both of them are excited to keep pushing the boundaries of wound care innovation.
- ConvaMaxTM, a hyper absorbent wound dressing for the management of highly oozing wounds such as leg ulcers, diabetic foot ulcers, and others, was released by ConvaTec Group Plc in January 2020. As a result of the introduction of new therapy systems.
SKU-